X-151601572-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_173493.3(PASD1):​c.19A>G​(p.Lys7Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,096,997 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K7N) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 1 hem. )

Consequence

PASD1
NM_173493.3 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.689

Publications

0 publications found
Variant links:
Genes affected
PASD1 (HGNC:20686): (PAS domain containing repressor 1) This gene encodes a protein that is thought to function as a transcription factor. The protein is a cancer-associated antigen that can stimulate autologous T-cell responses, and it is therefore considered to be a potential immunotherapeutic target for the treatment of various hematopoietic malignancies, including diffuse large B-cell lymphoma. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.072316945).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PASD1NM_173493.3 linkc.19A>G p.Lys7Glu missense_variant Exon 2 of 16 ENST00000370357.5 NP_775764.2
PASD1XM_011531102.3 linkc.19A>G p.Lys7Glu missense_variant Exon 2 of 16 XP_011529404.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PASD1ENST00000370357.5 linkc.19A>G p.Lys7Glu missense_variant Exon 2 of 16 1 NM_173493.3 ENSP00000359382.4 Q8IV76-1
PASD1ENST00000464219.1 linkn.157A>G non_coding_transcript_exon_variant Exon 2 of 15 2

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD2 exomes
AF:
0.00000549
AC:
1
AN:
182200
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1096997
Hom.:
0
Cov.:
28
AF XY:
0.00000276
AC XY:
1
AN XY:
362361
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26363
American (AMR)
AF:
0.00
AC:
0
AN:
35163
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54015
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40524
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4130
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841197
Other (OTH)
AF:
0.00
AC:
0
AN:
46051
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000597

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 15, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.19A>G (p.K7E) alteration is located in exon 2 (coding exon 1) of the PASD1 gene. This alteration results from a A to G substitution at nucleotide position 19, causing the lysine (K) at amino acid position 7 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
1.2
DANN
Benign
0.62
DEOGEN2
Benign
0.00086
T
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.31
T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.69
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.13
N
REVEL
Benign
0.094
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.023
D
Polyphen
0.38
B
Vest4
0.20
MutPred
0.28
Loss of sheet (P = 0.0457);
MVP
0.043
MPC
0.039
ClinPred
0.086
T
GERP RS
-5.9
Varity_R
0.16
gMVP
0.26
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768226760; hg19: chrX-150770044; API